Research ArticleCancer

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Sci. Signal.  25 Mar 2014:
Vol. 7, Issue 318, pp. ra29
DOI: 10.1126/scisignal.2005125

Log in to view full text

Via your Institution

Log in through your institution

Log in through your institution


Navigate This Article